Trial · NCT02600390
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Safety of treatment as determined by changes in vital signs, electrocardiographic, biochemical, hematological, and urinalysis measures, and reported adverse events | 8 or 10 weeks | |
| Primary | Change in Sickle Cell Disease leg ulcer wound pain scores as measured by a 10-point scale, relative to non-wound site pain scores | 8 or 10 weeks | |
| Primary | Rate and extent of leg ulcer wound healing as measured by change in wound surface area | 8 or 10 weeks | |
| Secondary | Changes in leg ulcer wound status as measured by need for debridement (type and quantity of non-viable tissue) | 8 or 10 weeks | |
| Secondary | Changes in leg ulcer wound status as measured by extent of exudate production | 8 or 10 weeks | Change in quality of life as measured by SF-12 Health Survey (acute version) as well as other indicators of patient comfort and well-being |
| Secondary | Changes in leg ulcer wound status as measured by type and amount of granulation tissue | 8 or 10 weeks | |
| Secondary | Changes in leg ulcer wound status as measured by overall change in leg ulcer wound appearance | 8 or 10 weeks | |
| Secondary | Change in local skin in the region of the leg ulcer as measured by skin appearance (coloration, inflammation, etc.) | 8 or 10 weeks | |
| Secondary | Change in local skin in the region of the leg ulcer as measured by skin temperature (relative to body temperature) | 8 or 10 weeks | |
| Secondary | Improvement in leg ulcer wound severity as measured by Venous Clinical Severity Score (VCSS) | 8 or 10 weeks | |
| Secondary | Change in quality of life, as measured by an SF-12 Health Survey (acute version) as well as other indicators of patient comfort and well-being | 8 or 10 weeks |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02600390/registered